Chartwell Investment Partners’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $522K | Buy |
5,808
+45
| +0.8% | +$4.04K | 0.02% | 398 |
|
|
2024
Q2 | $464K | Sell |
5,763
-943
| -14% | -$75.9K | 0.02% | 398 |
|
|
2024
Q1 | $536K | Buy |
+6,706
| New | +$536K | 0.02% | 396 |
|
|
2021
Q3 | – | Sell |
-16,261
| Closed | -$1.1M | – | 430 |
|
|
2021
Q2 | $1.1M | Buy |
16,261
+146
| +0.9% | +$9.85K | 0.03% | 367 |
|
|
2021
Q1 | $912K | Sell |
16,115
-865
| -5% | -$49K | 0.03% | 366 |
|
|
2020
Q4 | $1.38M | Buy |
16,980
+9,433
| +125% | +$768K | 0.04% | 328 |
|
|
2020
Q3 | $538K | Hold |
7,547
| – | – | 0.02% | 389 |
|
|
2020
Q2 | $621K | Sell |
7,547
-2,765
| -27% | -$228K | 0.02% | 366 |
|
|
2020
Q1 | $607K | Sell |
10,312
-13,027
| -56% | -$767K | 0.03% | 354 |
|
|
2019
Q4 | $2.41M | Buy |
+23,339
| New | +$2.41M | 0.08% | 262 |
|